Log In
Register
Facebook icon
LinkedIn icon
Instagram icon
Cosmetic Ingredients
Formulas/Products
Research
Regulations
Testing
News
Leaders
Multimedia
Calendar
Home
Search
Search Cosmetics & Toiletries: Page 2
Article
Company
Document
Event
News
Podcast
Video
Webcast
Cosmetic Ingredients
Formulas/Products
Multimedia
News
Regulations
Claims/Labeling
Research
Testing
Enter search phrase
Search
82 Results
Section: Regulations > Claims/Labeling
Claims/Labeling
FDA Issues Warning Over Hand Sanitizer Claims
The US Food and Drug Administration (FDA) has issued a warning letter to Procter & Gamble Co. over hand sanitizer claims.
Regional
FDA Releases Color Additives Q4 Report
The U.S. Food and Drug Administration (FDA) has posted to its website the fourth quarter 2020 report on color additive certifications.
Regional
FDA Sets Regulatory Framework for Regenerative Biological Therapies
It's a sign of the times when technology and innovation hit a point where the U.S. Food and Drug Administration must stop and write new rules to ensure consumer safety. That time, with respect to regenerative biological therapies, is now.
Claims/Labeling
Road to Regulation: Microneedling Devices Defined by FDA
Microneedling devices have, for some time, been without widely enforced regulation. As such, the U.S. Food and Drug Administration released a draft guidance on Sept. 15, 2017, defining when tools are considered esthetic vs. medical in nature, along with potential regulatory changes.
Regional
FDA Warns Brazilian Blowout for Methylene Glycol Formulation
The US Food and Drug Administration (FDA) has sent a warning letter to Brazilian Blowout for its Açai Professional Smoothing Solution. The FDA finds the product to be misbranded by stating on its label that it does not contain formaldehyde and is adulterated by containing methylene glycol, a liquid form of formaldehyde.
Skin Care
UPDATED: FDA Bans 24 Antiseptic Ingredients Including Triclosan
Along with triclosan, the FDA has banned 23 other ingredients used in health care antiseptics, finding their safety and efficacy insufficient.
Claims/Labeling
FDA Sued Over Salon Products Containing Formaldehyde
The groups claim that the FDA has not sufficiently reacted to the concerns regarding the health risks that salon keratin hair products containing formaldehyde present.
Claims/Labeling
FDA Releases Draft Guidance Toward Nanotech Regulation
The US Food and Drug Administration (FDA) has released a draft guidance outlining its view on how to identify whether regulated products contain nanomaterials or apply such technologies.
Claims/Labeling
What Dermatologists, FDA Say about Halloween Makeup
Spooky makeup fills novelty shops this time of year, but what did dermatologists and other experts have to say about safety and ingredients?
Claims/Labeling
FDA and Academia: Institutions to Collaborate Under Nanotech Initiative
Over-arching goals have spurred a collaboration to develop safe and effective nano-engineered products. While these efforts concentrate on medical use, implications for personal care are on the horizon.
Regulations
U.S. FDA Issues 15 Warning Letters Over CBD Products
“We remain concerned that some people wrongly think that the myriad of CBD products on the market, many of which are illegal, have been evaluated by the FDA and determined to be safe," said FDA principal deputy commissioner Amy Abernethy, M.D., Ph.D.
Claims/Labeling
Talcum and Toxins Lawsuit Escalates, FDA Calls Meeting on Talc Testing
Several major talcum powder marketers are being slapped with a new lawsuit alleging their products contain undisclosed dangerous substances. In relation, the U.S. FDA has called a public meeting, to be held on Feb. 4, 2020, regarding testing for asbestos in talc and talc-containing cosmetic products.
Claims/Labeling
FDA Warns About Stimulating Collagen, Lightening and Other Claims
This article reminds us that the FDA has issued a warning about claims which would imply certain cosmetics would be considered drugs under the Federal Food, Drug and Cosmetic Act.
Claims/Labeling
Diatomaceous Earth and Comfrey Root Catch the FDA's Eye
This is a good reminder for cosmetic manufacturers to be careful when straddling the line between a cosmetic and drug. It's all in the claims.
Claims/Labeling
FDA Issues Warning Letter for Eyebrow/Eyelash Growth Product Claims
Cosmetic manufacturer Lifetech Resources LLC has been issued a warning letter by the US Food and Drug Administration (FDA) regarding claims touted on three of its eye care products.
Claims/Labeling
FDA to Use Adverse Event Reports to Monitor Cosmetic Safety
AERs that are submitted usually deal with hair products including shampoos, conditioners, hair smoothing products and hair dyes as well as skin products.
Claims/Labeling
FDA Adds Cosmetic Manufacturers to Import Alert for Drug Claims
The US Food & Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER) has re-issued an import alert that scrutinizes cosmetic manufacturers importing antiaging products into the United States that make drug claims.
Claims/Labeling
ICMAD Responds to Suit Against FDA Over Nanotechnology
In response to the suit filed against the US Food and Drug Administration (FDA) by a coalition of six consumer safety and environmental groups over the FDA's lack of nanotechnology regulation, Independent Cosmetic Manufacturers & Distributors (ICMAD) has sent an exclusive response to
Cosmetics & Toiletries
magazine, as shown here.
Previous Page
Page 2 of 5
Next Page